Clinical trials
Cutaneous Squamous Cell Carcinoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
106 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 5 |
| 2018 | 2 |
| 2019 | 9 |
| 2020 | 13 |
| 2021 | 12 |
| 2022 | 12 |
| 2023 | 16 |
| 2024 | 10 |
| 2025 | 5 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 27 |
| Recruiting | 25 |
| Active, not recruiting | 15 |
| Terminated | 14 |
| Unknown status | 11 |
| Withdrawn | 10 |
| Enrolling by invitation | 2 |
| No longer available | 1 |
| Available | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Regeneron Pharmaceuticals | 7 |
| Maastricht University Medical Center | 5 |
| H. Lee Moffitt Cancer Center and Research Institute | 4 |
| Incyte Corporation | 3 |
| Memorial Sloan Kettering Cancer Center | 3 |
| National Cancer Institute (NCI) | 3 |
| TuHURA Biosciences, Inc. | 3 |
| Dana-Farber Cancer Institute | 2 |
| Henan Cancer Hospital | 2 |
| Massachusetts General Hospital | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cutaneous Squamous Cell Carcinoma | 106 |
| Skin Neoplasms | 29 |
| Basal Cell Carcinoma | 22 |
| Melanoma | 20 |
| Squamous Cell Carcinoma of Head and Neck | 20 |
| Carcinoma, Merkel Cell | 18 |
| Carcinoma, Squamous Cell | 17 |
| Neoplasm Metastasis | 10 |
| Carcinoma, Non-Small-Cell Lung | 9 |
| Carcinoma, Renal Cell | 8 |
Trials
Showing 1 to 25 of 106. Each trial links to its page on Pharma Observatory.
6 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.